Pharmagreen Biotech Stock Investor Sentiment

PHBI Stock  USD 0  0.0001  5.88%   
Under 51% of Pharmagreen Biotech's traders are presently thinking to get in. The analysis of overall sentiment of trading Pharmagreen Biotech pink sheet suggests that some investors are interested at this time. Pharmagreen Biotech's investing sentiment shows overall attitude of investors towards Pharmagreen Biotech.
  
over a month ago at news.google.com         
Pharmagreen Biotech Inc. Announces Exciting Revenue Potential for Its Project - Yahoo Finance
Google News at Macroaxis
over two months ago at news.google.com         
Pharmagreen Biotech, Inc. Reaffirms Commitment to Non-Toxic Financing Amid Ongoing Business Developm...
Google News at Macroaxis
over six months ago at news.google.com         
PHBI - Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil in Its Nutraceutical...
Google News at Macroaxis
over a year ago at news.google.com         
2023-09-05 OTCPKPHBI Press Release Pharmagreen Biotech Inc - Stockhouse Publishing
Google News at Macroaxis
over a year ago at news.google.com         
Pharma good for next 2-3 years wait a quarter before entering IT Abhishek Basumallick - The Economic...
Google News at Macroaxis
over a year ago at news.google.com         
Air Wisconsin Airlines the Rise of Harbor Diversified Inc - MicroCap Daily
Google News at Macroaxis
over a year ago at news.google.com         
Form 10-Q Pharmagreen Biotech Inc. For Mar 31 - StreetInsider.com
Google News at Macroaxis
over a year ago at news.google.com         
Creso Pharma hones in on pivotal Asian markets with Singapore ... - Proactive Investors Australia
Google News at Macroaxis
over a year ago at news.google.com         
PEAR THERAPEUTICS, INC. Notice of Delisting or Failure to ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Oliver Healthcare Packaging breaks ground on its largest facility in ... - BSA bureau
Google News at Macroaxis
over a year ago at news.google.com         
PHBI Pharmgreen Launches Online Sales for Its MaxGenomic Supplement Product - Marketscreener.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pharmagreen Biotech that are available to investors today. That information is available publicly through Pharmagreen media outlets and privately through word of mouth or via Pharmagreen internal channels. However, regardless of the origin, that massive amount of Pharmagreen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pharmagreen Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pharmagreen Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pharmagreen Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pharmagreen Biotech alpha.

Pharmagreen Biotech Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Pharmagreen Pink Sheet analysis

When running Pharmagreen Biotech's price analysis, check to measure Pharmagreen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagreen Biotech is operating at the current time. Most of Pharmagreen Biotech's value examination focuses on studying past and present price action to predict the probability of Pharmagreen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagreen Biotech's price. Additionally, you may evaluate how the addition of Pharmagreen Biotech to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing